Austrian drug maker’s restructuring succumbs to coronavirus pandemic
An Austrian drugs and medical equipment manufacturer, whose restructuring was being overseen by Stefan Riel, will now enter liquidation after investors pulled out of a capital increase citing the coronavirus pandemic’s impact on sales.
To read more
Subscribe to Global Restructuring Review
Subscribe & start reading now!
GRR is a daily information service providing cross-border insolvency and restructuring news, features and events.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10